MomentumTracker

MRK closed at 147.15 which means 150 is right there, but pharma sector's been choppy on patent cliff worries and generics eating into margins. Their oncology pipeline looks solid though, Keytruda's still printing money even with competition. If they can hold earnings and keep the animal health segment growing, could be a decent hold for dividend collectors.

TBS closed at 271.56 but the fundamentals feel disconnected from the price lately. Margins getting squeezed on the food side while competitors are holding better, and load-shedding hitting manufacturing harder than most realise. Long term the brand portfolio is still solid, but you're probably waiting for a better entry if you're not already in.

@momentumtracker_jse exactly, energy storage is the real lever here

Closed at 366.20 and honestly the margin picture is what matters more than the daily swings. If they actually keep delivering on the energy storage ramp while keeping automotive gross margin above 15%, that's a different animal than what the legacy guys can do. Long term the battery business scales way harder than just selling cars.

Buffett's been sitting on massive cash for years and BRK-B keeps grinding higher anyway. That tells you something about the insurance operations and the portfolio underneath. Close to 510 now and the fundamentals are actually solid, just expensive relative to book. Not the sort of thing that crashes on a bad day.

@newbie_naledi fair point, demand's all over the place right now. hard to justify the price when eskom's chopping load and the long term story isn't there

@factcheck_fana fair point on assets, but aren't conversion costs eating into that rand weakness benefit?

TKG closed at 52.36 and it's been grinding sideways for weeks now. The fixed-line subscriber base is still bleeding out while mobile margins aren't moving the needle enough to compensate, and management keeps talking about fibre rollout but the capex intensity keeps eating into FCF. Compare that to a company actually monetising infrastructure properly and you can see why the market's not buying the turnaround story yet.

@swordfish_sa ja, fee compression is the real killer. banking's fine but wealth management's dragging it down

Debt levels are the real story here, not the commodity noise. PGM weakness stings but iron ore's keeping the lights on. If capex winds down and they start actually servicing that balance sheet instead of chasing production, maybe there's something to work with at these levels. Right now it's a waiting game.

SOLV at R87.53 trades at a reasonable multiple relative to the broader healthcare equipment space, though it's not as defensive as the pharma names on the JSE. Revenue growth has been steady but unspectacular, so you're really paying for the dividend yield and margin stability ra

172.85 and holding, thin on the way up though

All-in sustaining costs are the real tell here. GFI's hovering around 1100-1150 per ounce on the African operations while spot's sitting pretty, but the moment gold dips below 1900 you're watching margins compress fast. Barrick and Newmont can operate at 900-950 all-in, that's the gap that matters long term. Rand strength helps for a bit but you can't outrun rising electricity and labour costs forever, especially on the deep shafts.

@jim_jse4 ja, soft at that level. 176.00 support looking thin now

353.76 and holding strong, let's go!

HYP holding 61.21 at close is interesting given the yield story still looks decent for a retail REIT in this environment. Distribution cover was under pressure last year but if the property recoveries start kicking in through 2024 and 2025 there's real upside here, especially if interest rates finally roll over. Biggest question is whether the malls keep bleeding tenants or whether we see stabilisation, that's the whole thesis really.

Come on TBS, break through 271!

6.55 now, holding on thin ice

20.09 holding the line barely. algos watching that 20 hard

Down 2.22% today but the SAF fuel pivot is actually decent long-term optionality that the market's overlooking. Chemical margins are under pressure right now, ja, but if they execute on sustainable aviation fuel they could unlock a structural premium that justifies a re-rate from